Asthma inhalers could increase the risk of being affected with diabetes, so be aware, as suggested by a study.
The study was carried out by researchers at Lady Davis Institute for Medical Research, Montreal. The researchers concluded that inhaling steroids could pose a threat of diabetes, so those suffering with lung disease should consult their physicians about the use of synthetic hormone medication, as higher the dose, more is the risk.
The findings of the study appeared in the American Journal of Medicine and the team of researchers were led by Samy Suissa, Director of the Centre for Clinical Epidemiology at the Lady Davis Institute for Medical Research of the Jewish General Hospital.
The research involved analysis on 400,000 patients, whose database was collected from the Quebec health insurance board. The patients were tracked for 18 years. It was found that the inhaled steroids increased the risk of diabetes by 34% every year to 19 per 1,000 from 14 people per 1,000.
Inhaled steroids prove beneficial to asthma patients by checking the airway inflammation that could cause deadly attacks. But, it is not beneficial for COPD (chronic obstructive pulmonary disease); as such patients' lung dysfunction is caused by smoking. But, nearly 70% of CPOD patients depend on high doses of bronco-dilator sprays and micropowders.
Suissa suggested that inhalers should be suggested to asthma patients by physicians, while they will be prescribed to COPD patients in low-doses after assessing their condition.